The DOI matches its Crossref record.
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response.
Abstract
We investigated in vivo the expression of the tissue inhibitor of metalloproteinases-1 (TIMP-1) in the rat CNS after kainate (KA)-induced excitotoxic seizures.In situ hybridization revealed that TIMP-1 mRNA is induced rapidly and massively in most regions of the adult forebrain after KA treatment. Neuronal activity seems to be necessary but not sufficient to trigger TIMP-1 induction, because it is not observed in seizing 10-d-old pups, unlike what is observed in 21- and 35-d-old animals after seizures. The rapid induction of TIMP-1 is not prevented by the inhibitor of protein synthesis cycloheximide, suggesting that, after seizures, TIMP-1 is induced in neurons as an immediate early gene (IEG). The initial neuronal upregulation is followed by enhanced expression in astrocytes, as assessed by double-labeling experiments. In the hippocampus rapid increases in mRNA are followed by relatively delayed (8 hr after KA) increases in TIMP-1 immunoreactivity in the perisomatic and dendro–axonic areas, suggesting secretion of the protein. At 3 d after KA treatment, strong immunoreactivity is found in astrocytes and in the cell bodies and dendro–axonic projections of resistant neurons such as the dentate granule cells. Taken together, the results suggest that TIMP-1 may be instrumental for neurons and astrocytes in coupling early cellular events triggered by seizures with the regulation of long-lasting changes involved in tissue reorganization and/or neuroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the diseased brain, reactive astrocytes are the main cellular source of TIMP-1.
“In the diseased brain, reactive astrocytes are the main cellular source of TIMP-1 (Rivera et al., 1997, 2002; Pagenstecher et al., 1998)”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Rivera et al., 1997
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 74
- Apodaca, 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells., Cancer Res, 50, 2322
- 10.1006/geno.1994.1016 · DOI
- 10.1016/0306-4522(80)90049-4 · DOI
- 10.1016/0306-4522(81)90193-7 · DOI
- 10.1111/1523-1747.ep12483956 · DOI
- 10.1093/nar/23.24.5041 · DOI
- 10.1111/j.1460-9568.1994.tb00247.x · DOI
- 10.1042/bj1950159 · DOI
- 10.1523/JNEUROSCI.15-07-05088.1995 · DOI
- Chua, 1990, Tumor necrosis factor-α induces mRNA for collagenase and TIMP in human skin fibroblasts., Connect Tissue Res, 25, 161, 10.3109/03008209009006990 · DOI
- Dayer, 1994, Interleukin-1, tumor necrosis factor and their specific inhibitors., Eur Cytokine Netw, 5, 563
- 10.1097/00001756-199604260-00004 · DOI
- 10.1038/318066a0 · DOI
- 10.1016/0896-6273(92)90133-X · DOI
- 10.1128/MCB.5.11.3280 · DOI
- Edwards, 1987, Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor., EMBO J, 6, 1899, 10.1002/j.1460-2075.1987.tb02449.x · DOI · Paper page
- Edwards, 1992, Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription., Biochim Biophys Acta, 1171, 41, 10.1016/0167-4781(92)90138-P · DOI
- Emonard, 1990, Matrix metalloproteinases. A review., Cell Mol Biol, 36, 131
- Ferhat L, Represa A, Zouaoui-Aggoun D, Ferhat W, Ben-Ari Y, Khrestchatisky M (1997) FGF-2 induces nerve growth factor expression in cultured rat hippocampal neurons. Eur J Neurosci, in press. · DOI
- 10.1523/JNEUROSCI.16-06-02057.1996 · DOI
- 10.1016/0169-328X(94)90250-X · DOI
- 10.1038/315768a0 · DOI
- 10.1111/j.1460-9568.1995.tb01071.x · DOI
- Goto, 1990, Effects of cycloheximide on delayed neuronal death in rat hippocampus., Brain Res, 534, 105, 10.1016/0006-8993(90)90144-Z · DOI
- Gottschall, 1995, Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes., J Neurochem, 64, 1513, 10.1046/j.1471-4159.1995.64041513.x · DOI
- 10.1016/0014-5793(92)80015-9 · DOI
- 10.1038/nbt0695-554 · DOI
- 10.1016/0306-4522(93)90065-N · DOI
- 10.1016/0014-4886(79)90199-7 · DOI
- 10.1126/science.2465572 · DOI
- 10.1523/JNEUROSCI.16-23-07428.1996 · DOI
- Leco, 1994, Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues., J Biol Chem, 269, 9352, 10.1016/S0021-9258(17)37115-6 · DOI
- 10.1073/pnas.88.16.7233 · DOI
- 10.1523/JNEUROSCI.12-03-00872.1992 · DOI
- 10.1126/science.6144182 · DOI
- 10.1016/0006-291X(90)91221-D · DOI
- 10.1007/BF00144019 · DOI
- 10.1016/0166-2236(88)90182-8 · DOI
- 10.1146/annurev.ne.14.030191.002225 · DOI
- Murphy, 1977, The detection and characterisation of collagenase inhibitors from rabbit tissues in culture., Biochim Biophys Acta, 483, 493, 10.1016/0005-2744(77)90080-8 · DOI
- Murphy, 1985, Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture., J Biol Chem, 260, 3079, 10.1016/S0021-9258(18)89475-3 · DOI
- 10.1021/bi00247a001 · DOI
- 10.3171/jns.1994.81.1.0069 · DOI
- 10.1111/j.1460-9568.1995.tb01148.x · DOI
- 10.1038/363718a0 · DOI
- 10.1016/0006-8993(93)90569-9 · DOI
- 10.1016/0304-3940(94)90902-4 · DOI
- 10.1007/BF01257376 · DOI
- 10.1016/0306-4522(84)90289-6 · DOI
- 10.1016/0378-1119(94)90088-4 · DOI
- 10.1016/0006-291X(90)91190-4 · DOI
- 10.1111/j.1460-9568.1992.tb00185.x · DOI
- 10.1126/science.271.5256.1731 · DOI
- 10.1038/361453a0 · DOI
- Rajan, 1995, LIF-mediated activation of STAT proteins after neuronal injury in vivo., NeuroReport, 6, 2240, 10.1097/00001756-199511000-00033 · DOI
- Reeben, 1996, Role of a calcium-activated metalloprotease stromelysin-1 (transin) in the brain damage during epileptic seizures., J Neurochem, 66, S56
- 10.1002/neu.480260313 · DOI
- Rivera, 1994, Interleukin-1β increases basic fibroblast growth factor mRNA expression in adult rat brain and organotypic hippocampal cultures., Mol Brain Res, 27, 12, 10.1016/0169-328X(94)90179-1 · DOI
- 10.1089/neu.1995.12.833 · DOI
- 10.1016/0006-8993(92)90681-X · DOI
- 10.1097/00004647-199605000-00002 · DOI
- 10.1146/annurev.bi.64.070195.003201 · DOI · Paper page
- 10.1016/0306-4522(80)90181-5 · DOI
- 10.1016/0304-3940(92)90640-S · DOI
- Shingu, 1993, The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells., Clin Exp Immunol, 94, 145, 10.1111/j.1365-2249.1993.tb05992.x · DOI
- 10.1523/JNEUROSCI.09-05-01579.1989 · DOI
- 10.1093/nar/10.10.3069 · DOI
- 10.1095/biolreprod46.5.772 · DOI
- 10.1007/BF00049520 · DOI
- Stetler-Stevenson, 1989, Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family., J Biol Chem, 264, 17374, 10.1016/S0021-9258(18)71503-2 · DOI
- 10.1016/0306-4522(84)90288-4 · DOI
- 10.1038/377340a0 · DOI
- 10.1523/JNEUROSCI.14-03-01688.1994 · DOI
- 10.1016/0006-8993(91)90385-9 · DOI
Cited by
Sorted by citations
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499
Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. G., & Kaczmarek, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00920.2002 · Cited by 392
Muir, E. M., Adcock, K. H., Morgenstern, D. A., Clayton, R., von Stillfried, N., Rhodes, K., Ellis, C., Fawcett, J. W., & Rogers, J. H. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00132-8 · Cited by 206
MMPs in learning and memory and neuropsychiatric disorders
Beroun, A., Mitra, S., Michaluk, P., Pijet, B., Stefaniuk, M., & Kaczmarek, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03180-8 · Cited by 207
Bozdagi, O., Nagy, V., Kwei, K. T., & Huntley, G. W. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00202.2007 · Cited by 182
Jourquin, J., Tremblay, E., Décanis, N., Charton, G., Hanessian, S., Chollet, A., Le Diguardher, T., Khrestchatisky, M., & Rivera, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02876.x · Cited by 178
Self-citationMatrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy
Rempe, R. G., Hartz, A. M. S., Soldner, E. L. B., Sokola, B. S., Alluri, S. R., Abner, E. L., Kryscio, R. J., Pekcec, A., Schlichtiger, J., & Bauer, B. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2751-17.2018 · Cited by 162
García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 88
Self-citationSmith, A. C. W., Scofield, M. D., & Kalivas, P. W. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.027 · Cited by 71
Takács, E., Nyilas, R., Szepesi, Z., Baracskay, P., Karlsen, B., Røsvold, T., Bjørkum, A. A., Czurkó, A., Kovács, Z., Kékesi, A. K., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.003 · Cited by 63
Tinnes, S., Schäfer, M. K. E., Flubacher, A., Münzner, G., Frotscher, M., & Haas, C. A. (2011) · The FASEB Journal · doi:10.1096/fj.10-168294 · Cited by 58
TIMP-1 inhibits the proteolytic processing of Reelin in experimental epilepsy
Tinnes, S., Ringwald, J., & Haas, C. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-224899 · Cited by 39
Ontogeny of MMPs and TIMPs in the murine neocortex.
Bednarek, N., Clément, Y., Lelièvre, V., Olivier, P., Loron, G., Garnotel, R., & Gressens, P. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181973aee · Cited by 35
Rylski, M. (2004) · Frontiers in Bioscience · doi:10.2741/1207 · Cited by 33
Metadata
- Authors
- Rivera, S., Tremblay, E., Timsit, S., Canals, O., Ben-Ari, Y., & Khrestchatisky, M.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1997-06-01
- Volume
- 17
- Issue
- 11
- Pages
- 4223-4235
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 135
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review